WVE Q2 2021 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-8.3% YoY

Gross Profit

-$29M-1039.6% margin

Operating Income

-$40M-1434.7% margin

Net Income

-$39M-1396.5% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$206M

Total Liabilities

$185M

Stockholders' Equity

$22M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-8.3%
Gross Profit	-$29M	-$28M	-1.4%
Operating Income	-$40M	-$39M	-3.0%
Net Income	-$39M	-$41M	+4.3%

Revenue Segments

Research Term

$19M100%